A multicentre, double-blind, active controlled trial to evaluate the clinical effects of immediate release paroxetine and controlled release paroxetine in the treatment of major depression.

Trial Profile

A multicentre, double-blind, active controlled trial to evaluate the clinical effects of immediate release paroxetine and controlled release paroxetine in the treatment of major depression.

Completed
Phase of Trial: Phase III

Latest Information Update: 23 Apr 2013

At a glance

  • Drugs Paroxetine (Primary)
  • Indications Major depressive disorder
  • Focus Registrational; Therapeutic Use
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 07 Jun 2010 Primary endpoint 'Hamilton Depression Rating Scale' has been met.
    • 07 Jun 2010 Results have been presented at the 27th International Congress of Collegium Internationale Neuro Psychopharmacologicum.
    • 26 Nov 2007 Status changed from recruiting to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top